LCN2 and Familial prostate cancer: Others might inhibit genes of FNBP1L, ZC4H2, MMP16, PPP1R9A, AFF3, MAGI3, KIAA1217, ZFHX3, TANC1, PRKCZ, and PDZD2 which were identified as a prostate cancer dependency-regulating RNA splicing [35]; FNBP1L, SLC4A7, DSG2, MAGI3, KIAA1217, TANC1, PRKCZ, NCAM1, and OLFM4 involving in cell-to-cell interactions that facilitate cell adhesion and inversion [36]; and LCN2 (NGAL) and OLFM4 (GW112) selectively express in colon cancer and serve as selective targets [37].